All Stories

  1. Atypical Presentation of IARS1‐Related Disorder: Expanding the Phenotype and Genotype
  2. Treatment and Improved Outcomes of Three Adult Patients With Guanidinoacetate Methyltransferase (GAMT) Deficiency
  3. Child Neurology: Five-Year Update on Siblings With Riboflavin Transporter Deficiency
  4. Case report: ocular manifestations of a gain-of-function mutation in CLCN6 , a newly diagnosed disease
  5. Primary Mitochondrial Disorders in the Neonate
  6. DDOST‐CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype
  7. Tumor predisposition: what's the skin got to do with it?
  8. Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis
  9. Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders
  10. A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1
  11. Autosomal Dominant ANO5-Related Disorder Associated With Myopathy and Gnathodiaphyseal Dysplasia
  12. Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype
  13. Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome
  14. Biallelic variants in RNU12 cause CDAGS syndrome
  15. Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function
  16. Biallelic ASCC1 variants including a novel intronic variant result in expanded phenotypic spectrum of spinal muscular atrophy with congenital bone fractures 2 (SMABF2)
  17. Familial segregation of neuropsychiatric phenotypes and a 5’UTR deletion in PTPRD
  18. Correction to: De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy
  19. De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy
  20. Paroxysmal Kinesigenic Dyskinesia in Twins With Chromosome 16p11.2 Duplication Syndrome
  21. New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra
  22. Novel exon-skipping variant disrupting the basic domain of HCFC1 causes intellectual disability without metabolic abnormalities in both male and female patients
  23. Response to Mounts and Besser
  24. Delineation of the 1q24.3 microdeletion syndrome provides further evidence for the potential role of non-coding RNAs in regulating the skeletal phenotype
  25. A Recurrent Gain-of-Function Mutation in CLCN6, Encoding the ClC-6 Cl−/H+-Exchanger, Causes Early-Onset Neurodegeneration
  26. Overcoming presynaptic effects of VAMP2 mutations with 4‐aminopyridine treatment
  27. Wilms tumor in patients with osteopathia striata with cranial sclerosis
  28. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects
  29. Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7
  30. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG)
  31. Delineation of phenotypes and genotypes related to cohesin structural protein RAD21
  32. Abnormally increased carotid intima media-thickness and elasticity in patients with Morquio A disease
  33. Pathogenic variants in TNRC6B cause a genetic disorder characterised by developmental delay/intellectual disability and a spectrum of neurobehavioural phenotypes including autism and ADHD
  34. Intragenic CNTN4 copy number variants associated with a spectrum of neurobehavioral phenotypes
  35. Delineation of a Human Mendelian Disorder of the DNA Demethylation Machinery: TET3 Deficiency
  36. Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
  37. Sorting nexin 27 (SNX27) variants associated with seizures, developmental delay, behavioral disturbance, and subcortical brain abnormalities
  38. CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum
  39. Variants in TCF20 in neurodevelopmental disability: description of 27 new patients and review of literature
  40. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
  41. De novo substitutions of TRPM3 cause intellectual disability and epilepsy
  42. Phenotype and response to growth hormone therapy in siblings with B4GALT7 deficiency
  43. 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
  44. A mutation in Site‐1 Protease is associated with a complex phenotype that includes episodic hyperCKemia and focal myoedema
  45. Pathogenic Variants in GPC4 Cause Keipert Syndrome
  46. A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity
  47. Variants in DOCK3 cause developmental delay and hypotonia
  48. Novel parent-of-origin-specific differentially methylated loci on chromosome 16
  49. Birth Defects Among 788 Children Born to Gulf War Veterans Based on Physical Examination
  50. De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-progressive Neurocognitive Syndrome
  51. Inherited Deletion of 1q, Hyperparathyroidism and Signs of Y-chromosomal Influence in a Patient with Turner Syndrome
  52. De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome
  53. Lamin B receptor-related disorder is associated with a spectrum of skeletal dysplasia phenotypes
  54. Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic
  55. Child Neurology: Brown-Vialetto-Van Laere syndrome
  56. Variable cardiovascular phenotypes associated with SMAD2 pathogenic variants
  57. De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder
  58. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells
  59. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene
  60. Functional characterization of biallelic RTTN variants identified in an infant with microcephaly, simplified gyral pattern, pontocerebellar hypoplasia, and seizures
  61. Mutations in the PH Domain of DNM1 are associated with a nonepileptic phenotype characterized by developmental delay and neurobehavioral abnormalities
  62. Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5)
  63. DeSanto-Shinawi Syndrome: First Case in South America
  64. WNT Signaling Perturbations Underlie the Genetic Heterogeneity of Robinow Syndrome
  65. The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies
  66. The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results
  67. Survival among children with “Lethal” congenital contracture syndrome 11 caused by novel mutations in the gliomedin gene (GLDN )
  68. Adult-onset dystonia with marfanoid features
  69. Heterozygous variants in ACTL6A , encoding a component of the BAF complex, are associated with intellectual disability
  70. Support for the Diagnosis of CHARGE Syndrome—Reply
  71. Erratum to: The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications
  72. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression
  73. Prevalence of Semicircular Canal Hypoplasia in Patients With CHARGE Syndrome
  74. FBXL4defects are common in patients with congenital lactic acidemia and encephalomyopathic mitochondrial DNA depletion syndrome
  75. Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations
  76. Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity
  77. The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications
  78. The expanding clinical phenotype of Bosch-Boonstra-Schaaf optic atrophy syndrome: 20 new cases and possible genotype–phenotype correlations
  79. TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons
  80. A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects
  81. STXBP1 encephalopathy
  82. Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations
  83. Multigenerational autosomal dominant inheritance of 5p chromosomal deletions
  84. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome
  85. Mutations in COQ4, an essential component of coenzyme Q biosynthesis, cause lethal neonatal mitochondrial encephalomyopathy
  86. A Novel Mutation in Isoform 3 of the Plasma Membrane Ca2+ Pump Impairs Cellular Ca2+ Homeostasis in a Patient with Cerebellar Ataxia and Laminin Subunit 1α Mutations
  87. De Novo Mutations in SIK1 Cause a Spectrum of Developmental Epilepsies
  88. Digynic triploidy: utility and challenges of noninvasive prenatal testing
  89. De Novo Mutations in SIK1 Cause a Spectrum of Developmental Epilepsies
  90. Multi-systemic involvement in NGLY1-related disorder caused by two novel mutations
  91. TBX6 Null Variants and a Common Hypomorphic Allele in Congenital Scoliosis
  92. A 5-Month-Old Boy with Delay in Growth and Development and Decreased Muscle Tone
  93. Dosage Changes of a Segment at 17p13.1 Lead to Intellectual Disability and Microcephaly as a Result of Complex Genetic Interaction of Multiple Genes
  94. Fatty Acid Metabolism and Defects
  95. FGFR3-related condition: a skeletal dysplasia with similarities to thanatophoric dysplasia and SADDAN due to Lys650Met
  96. Brain MRI abnormalities and spectrum of neurological and clinical findings in three patients with proximal 16p11.2 microduplication
  97. Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes
  98. Autosomal recessive posterior column ataxia with retinitis pigmentosa caused by novel mutations in theFLVCR1gene
  99. Autism Spectrum Disorders
  100. Two novel RAD21 mutations in patients with mild Cornelia de Lange syndrome-like presentation and report of the first familial case
  101. Scoliosis and vertebral anomalies: Additional abnormal phenotypes associated with chromosome 16p11.2 rearrangement
  102. Molecular and phenotypic characterization of atypical Williams–Beuren syndrome
  103. Correction: Corrigendum: Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
  104. Haploinsufficiency of ZNF238 is associated with corpus callosum abnormalities in 1q44 deletions
  105. Heterozygous 24-polyalanine repeats in the PHOX2B gene with different manifestations across three generations
  106. NR2F1 haploinsufficiency is associated with optic atrophy, dysmorphism and global developmental delay
  107. Transient Massive Trimethylaminuria Associated with Food Protein–Induced Enterocolitis Syndrome
  108. Duplication of 20p12.3 associated with familial Wolff–Parkinson–White syndrome
  109. Duplication of OCRL and adjacent genes associated with autism but not Lowe syndrome
  110. ADULT syndrome due to an R243W mutation in TP63
  111. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism
  112. Acute Intermittent Porphyria
  113. Early‐onset Hepatic Fibrosis in Lysinuric Protein Intolerance
  114. Cobalamin F Disease Detected by Newborn Screening and Follow-up on a 14-Year-Old Patient
  115. Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats
  116. Desmosterolosis—phenotypic and molecular characterization of a third case and review of the literature
  117. 11p14.1 microdeletions associated with ADHD, autism, developmental delay, and obesity
  118. Known and Possible Roles of Epigenetics in Autism
  119. Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications
  120. Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
  121. Increased Homocysteine in a Patient Diagnosed with Marfan Syndrome
  122. Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyelia
  123. Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy
  124. McCune-Albright syndrome presenting with unilateral macroorchidism and bilateral testicular masses
  125. Mixed gonadal dysgenesis in a child with isodicentric y chromosome: Does the relative proportion of the 45,X line really matter?
  126. Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?
  127. 114 Expanding clinical spectrum of RRM2B mutations to include MNGIE
  128. Progressive Myopathy With Multiple Symmetric Lipomatosis
  129. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size
  130. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes
  131. Mitochondrial Neurogastrointestinal Encephalopathy Due to Mutations in RRM2B
  132. Microdeletions including YWHAE in the Miller–Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment
  133. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response
  134. The Xp contiguous deletion syndrome and autism
  135. The MTHFR 677C→T polymorphism and behaviors in children with autism: exploratory genotype–phenotype correlations
  136. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders
  137. Is this the Coffin–Siris syndrome or the BOD syndrome?
  138. Atypical presentation of VLCAD deficiency associated with a novel ACADVL splicing mutation
  139. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities
  140. The array CGH and its clinical applications
  141. 15q13q14 deletions: Phenotypic characterization and molecular delineation by comparative genomic hybridization
  142. Delineation of the proximal 3q microdeletion syndrome
  143. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster
  144. Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q
  145. Low‐level mosaicism of trisomy 14: Phenotypic and molecular characterization
  146. 29 Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome)
  147. 39 Formation of a Lysosomal Disease Testing Network to enhance the delivery of diagnostic services to patients with lysosomal storage disorders
  148. Lymphedema of the Lower Extremity: Is It Genetic or Nongenetic?
  149. Preaxial polydactyly in neurofibromatosis 1
  150. Hyperhomocysteinemia and cobalamin disorders
  151. Multiple ganglion cysts (‘cystic ganglionosis’): an unusual presentation in a child
  152. Erratum
  153. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
  154. Autoantibodies against bactericidal/permeability–increasing protein (BPI–ANCA) in cystic fibrosis patients treated with azithromycin
  155. Splicing mutation in the fibrillin‐1 gene associated with neonatal Marfan syndrome and severe pulmonary emphysema with tracheobronchomalacia
  156. Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: Utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol
  157. Extensive primary cutaneous herpes simplex virus type 1 infection in an infant following acute rotavirus gastroenteritis
  158. No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia
  159. Pulmonary manifestations and function tests in children genetically diagnosed with FMF
  160. Neurocristopathies presenting with neurologic abnormalities associated with Hirschsprung’s disease
  161. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever
  162. Crouzon syndrome: Association with absent pulmonary valve syndrome and severe tracheobronchomalacia
  163. Familial mediterranean fever: The segregation of four different mutations in 13 individuals from one inbred family: Genotype–phenotype correlation and intrafamilial variability
  164. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever
  165. Familial Mediterranean fever: prevalence, penetrance and genetic drift
  166. Fulminant Hepatitis Associated With Schistosoma mansoni
  167. Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain
  168. Neurodevelopmental Delay Associated With Nonconvulsive Status Epilepticus in a Toddler
  169. Neurodevelopmental Delay Associated With Nonconvulsive Status Epilepticus in a Toddler
  170. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease
  171. Familial Mediterranean Fever: Clinical and Genetic Characterization in a Mixed Pediatric Population of Jewish and Arab Patients
  172. Direct detection of common mutations in the familial Mediterranean fever gene (MEFV) using naturally occurring and primer mediated restriction fragment analysis
  173. CSF levels of carnitine in children with meningitis, neurologic disorders, acute gastroenteritis, and seizure